Showing results (1851-1860 of 2,288) with videos related to

Sort By:
Pageof 229
HIV Medicine|November 17, 2004
Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapyN M Keane, P Price, S Lee, et al.
HIV Medicine|November 17, 2004
Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infectionR Colebunders, E Bottieau, J Van den Brande, et al.
HIV Medicine|August 15, 2006
Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiationP Ingiliz, B Appenrodt, F Gruenhage, et al.
HIV Medicine|August 15, 2006
Fulminant toxoplasmosis causing fatal pneumonitis and myocarditisD E Eza, S B Lucas
HIV Medicine|September 2, 2006
National review of maternity care for women with HIV infectionC McDonald, H Curtis, A de Ruiter, et al.
HIV Medicine|September 2, 2006
'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherenceT S Barfod, H T Sørensen, H Nielsen, et al.
HIV Medicine|September 2, 2006
The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapyN I Paton, S Sangeetha, A Earnest, et al.
HIV Medicine|September 2, 2006
Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002M Schiavini, E Angeli, A Mainini, et al.
HIV Medicine|May 7, 2005
The durability of virological success of tenofovir and didanosine dosed at either 400 or 250 mg once dailyM-Y Tung, S Mandalia, M Bower, et al.
HIV Medicine|May 7, 2005
The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral loadM Bickel, V Rickerts, C Stephan, et al.
Pageof 229